Middle East Respiratory Syndrome
Yaseen M. Arabi(World Health Organization), Robert Fowler(Sunnybrook Health Science Centre), Ali H. Hajeer(King Saud bin Abdulaziz University for Health Sciences), J. Kenneth Baillie(NHS Lothian), Awad Al‐Omari(University of Central Florida), Frederick G. Hayden(University of Virginia Health System), Mikiko Senga(King Saud bin Abdulaziz University for Health Sciences), Hanan H. Balkhy(World Health Organization Regional Office for the Eastern Mediterranean), Abderrezak Bouchama(King Saud bin Abdulaziz University for Health Sciences), Mark R. Denison(Bipar), Maria D. Van Kerkhove(World Health Organization), James D. Chappell(King Saud bin Abdulaziz University for Health Sciences), Nahoko Shindo(World Health Organization), Thomas Luke(King Saud bin Abdulaziz University for Health Sciences), Alison Bermingham(King Saud bin Abdulaziz University for Health Sciences), Jonathan S. Nguyen‐Van‐Tam(King Saud bin Abdulaziz University for Health Sciences)
Cited by 511
Related Papers
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
|Intensive Care Medicine|2021|5.1k
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
An atlas of active enhancers across human cell types and tissues
|Nature|2014|2.8k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021
|Critical Care Medicine|2021|2.8k